HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadeusz Robak Selected Research

SDX 308

8/2008The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadeusz Robak Research Topics

Disease

125B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2022 - 01/2002
66Neoplasms (Cancer)
05/2022 - 03/2002
33Leukemia
01/2022 - 05/2002
27Multiple Myeloma
12/2021 - 12/2002
27Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 01/2003
21Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 07/2003
19Disease Progression
01/2022 - 01/2003
18Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 10/2002
17Infections
11/2021 - 02/2002
16Lymphoma (Lymphomas)
01/2022 - 12/2002
13Hairy Cell Leukemia
01/2022 - 02/2004
11Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2020 - 10/2006
11Neutropenia
01/2019 - 03/2002
9Fatigue
01/2022 - 05/2012
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2017 - 07/2002
7Residual Neoplasm
01/2022 - 02/2005
7Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020 - 02/2004
7Thrombocytopenia (Thrombopenia)
01/2020 - 11/2003
7Autoimmune Diseases (Autoimmune Disease)
12/2019 - 07/2004
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2019 - 12/2004
7Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2018 - 09/2007
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2016 - 03/2006
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2013 - 02/2002
6Cytopenia
06/2021 - 02/2004
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2015 - 01/2003
5Anemia
12/2021 - 03/2006
5Diarrhea
12/2021 - 07/2014
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 06/2008
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2014 - 05/2004
4Hemorrhage
12/2019 - 12/2015
4Nausea
12/2015 - 12/2007
4Lymphoid Leukemia
07/2014 - 02/2004
3Bone Diseases (Bone Disease)
12/2021 - 08/2003
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021 - 06/2008
3Pneumonia (Pneumonitis)
01/2019 - 01/2017
3Febrile Neutropenia
03/2018 - 08/2009

Drug/Important Bio-Agent (IBA)

51CladribineFDA LinkGeneric
01/2022 - 01/2002
46Rituximab (Mabthera)FDA Link
01/2022 - 02/2004
32Monoclonal AntibodiesIBA
01/2021 - 02/2004
30Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 01/2002
27fludarabineIBA
01/2020 - 03/2002
23Pharmaceutical PreparationsIBA
03/2021 - 06/2002
22ibrutinibIBA
05/2022 - 07/2012
21Bortezomib (Velcade)FDA Link
12/2021 - 12/2006
20Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2002
18Purine NucleosidesIBA
06/2021 - 03/2002
17Chlorambucil (Leukeran)FDA Link
01/2022 - 03/2002
17ofatumumabFDA Link
01/2020 - 02/2008
11CytokinesIBA
12/2021 - 01/2003
11Mitoxantrone (Novantrone)FDA LinkGeneric
01/2020 - 06/2002
11Prednisone (Sone)FDA LinkGeneric
01/2019 - 07/2002
11purineIBA
04/2017 - 09/2002
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 01/2003
10venetoclaxIBA
09/2022 - 03/2018
10Agammaglobulinaemia Tyrosine KinaseIBA
05/2022 - 07/2012
10Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020 - 02/2008
9Bendamustine HydrochlorideFDA Link
01/2022 - 11/2012
9Cytotoxins (Cytolysins)IBA
01/2019 - 03/2003
9Alemtuzumab (Campath)FDA Link
01/2013 - 02/2004
8idelalisibIBA
12/2021 - 08/2013
7Pentostatin (Nipent)FDA LinkGeneric
06/2021 - 03/2003
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 06/2002
7Alkylating AgentsIBA
07/2008 - 03/2002
6Phosphotransferases (Kinase)IBA
05/2022 - 01/2009
6acalabrutinibIBA
05/2022 - 11/2019
6immunotoxin HA22IBA
06/2021 - 05/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 10/2002
5AntibodiesIBA
01/2022 - 11/2012
5Immunoconjugates (Immunoconjugate)IBA
01/2019 - 01/2013
5Immunotoxins (Immunotoxin)IBA
01/2019 - 03/2008
5Vincristine (Oncovin)FDA LinkGeneric
01/2019 - 07/2008
5romidepsin (FK228)FDA Link
01/2018 - 10/2010
5Interleukin-10 (Interleukin 10)IBA
10/2017 - 03/2006
5liposomal doxorubicin (Doxil)FDA Link
07/2016 - 09/2007
51-dodecylpyridoxal (PLD)IBA
07/2016 - 09/2007
5forodesineIBA
12/2013 - 09/2007
4zanubrutinibIBA
05/2022 - 10/2020
4DNA (Deoxyribonucleic Acid)IBA
11/2021 - 07/2010
4Proteasome InhibitorsIBA
10/2021 - 03/2015
4Immunoglobulin G (IgG)IBA
01/2020 - 06/2009
4glasdegibIBA
01/2020 - 11/2018
4Daunorubicin (Cerubidine)FDA LinkGeneric
11/2018 - 01/2003
4Toll-Like Receptors (Toll-Like Receptor)IBA
10/2017 - 01/2009
4HLA Antigens (Human Leukocyte Antigens)IBA
06/2016 - 10/2002
4Dasatinib (BMS 354825)FDA Link
01/2015 - 06/2007
4nelarabine (506U78)FDA Link
12/2013 - 06/2008
4Clofarabine (Clolar)FDA Link
12/2013 - 06/2009
3Messenger RNA (mRNA)IBA
11/2021 - 12/2016
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021 - 01/2015
3CaspasesIBA
01/2021 - 07/2003
3obinutuzumabIBA
01/2020 - 06/2009
3Inosine Triphosphate (ITP)IBA
01/2020 - 10/2010
3serum P-component (CIt)IBA
11/2018 - 01/2018
3EnzymesIBA
06/2018 - 06/2003
3AnthracyclinesIBA
04/2017 - 06/2002
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 09/2006

Therapy/Procedure

66Therapeutics
05/2022 - 02/2002
27Drug Therapy (Chemotherapy)
01/2022 - 02/2002
9Stem Cell Transplantation
11/2020 - 03/2003
5Immunotherapy
06/2018 - 01/2009